EMA fast-tracks treatment of multiple myeloma for approval in EU

29 January 2016 - Empliciti is a monoclonal antibody that works by activating the body’s immune system to attack and kill multiple myeloma cells.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/01/news_detail_002461.jsp&mid=WC0b01ac058004d5c1

Michael Wonder

Posted by:

Michael Wonder